Albert Einstein Hospital developed a genetic test for the large-scale detection of the new coronavirus. The technique has high precision and can be considered a viable option for mass testing. The method has already had its patent registered through the International Patent System in the United States and will be available from June.
The exam developed by Einstein used as a basis the technology called Next Generation Sequencing (NGS), which analyzes small fragments of DNA to identify diseases. To detect Sars-Cov-2, the researchers adapted the method to read RNA, another biological molecule that is present in several types of viruses. According to the hospital, the test has 100% specificity, that is, it does not present cases of false positive and is the first genetic examination in the world to detect coronavirus on a large scale using the NGS sequencing technique.
Still, according to the researchers, the test’s effectiveness is equivalent to the RT-PCR type test, the main method for detecting the coronavirus applied worldwide, which detect the genetic material of the virus. However, the new exam presented by Einstein allows simultaneous analysis of up to 1,536 samples, 16 times more than RT-PCR.
I run this site in my spare time and thoroughly enjoy giving you all positive news! If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.